Cargando…
An engineered diatom acting like a plasma cell secreting human IgG antibodies with high efficiency
BACKGROUND: Although there are many different expression systems for recombinant production of pharmaceutical proteins, many of these suffer from drawbacks such as yield, cost, complexity of purification, and possible contamination with human pathogens. Microalgae have enormous potential for diverse...
Autores principales: | Hempel, Franziska, Maier, Uwe G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503769/ https://www.ncbi.nlm.nih.gov/pubmed/22970838 http://dx.doi.org/10.1186/1475-2859-11-126 |
Ejemplares similares
-
Engineering IgG-Like Bispecific Antibodies—An Overview
por: Krah, Simon, et al.
Publicado: (2018) -
Lymphocyte membrane IgG and secreted IgG are structurally and allotypically distinct
Publicado: (1980) -
Algae as Protein Factories: Expression of a Human Antibody and the Respective Antigen in the Diatom Phaeodactylum tricornutum
por: Hempel, Franziska, et al.
Publicado: (2011) -
Insights into the IgG heavy chain engineering patent landscape as applied to IgG4 antibody development
por: Dumet, Christophe, et al.
Publicado: (2019) -
IgG Fc engineering to modulate antibody effector functions
por: Wang, Xinhua, et al.
Publicado: (2017)